On Friday, enVVeno Medical Corporation (NASDAQ: NVNO) opened at On Friday, higher 10.06% from the last session, before settling in for the closing price of $3.48. Price fluctuations for NVNO have ranged from $2.03 to $6.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 14.96% at the time writing. With a float of $17.37 million, this company’s outstanding shares have now reached $17.54 million.
Considering the fact that the conglomerate employs 37 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 17.36%, operating margin of -2866.63%, and the pretax margin is -2626.85%.
enVVeno Medical Corporation (NVNO) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of enVVeno Medical Corporation is 0.93%, while institutional ownership is 20.83%. The most recent insider transaction that took place on Dec 31 ’24, was worth 249,999. In this transaction Director of this company bought 81,433 shares at a rate of $3.07, taking the stock ownership to the 102,344 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Director bought 3,500 for $2.94, making the entire transaction worth $10,290. This insider now owns 11,155 shares in total.
enVVeno Medical Corporation (NVNO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 14.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.48% during the next five years compared to 36.26% growth over the previous five years of trading.
enVVeno Medical Corporation (NASDAQ: NVNO) Trading Performance Indicators
Check out the current performance indicators for enVVeno Medical Corporation (NVNO). In the past quarter, the stock posted a quick ratio of 23.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of enVVeno Medical Corporation (NVNO)
Compared to the last year’s volume of 97979.0, its volume of 0.18 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 46.46%. Additionally, its Average True Range was 0.31.
During the past 100 days, enVVeno Medical Corporation’s (NVNO) raw stochastic average was set at 70.06%, which indicates a significant increase from 42.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.80% in the past 14 days, which was higher than the 70.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.08, while its 200-day Moving Average is $3.44. Nevertheless, the first resistance level for the watch stands at $4.43 in the near term. At $5.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.47. If the price goes on to break the first support level at $3.39, it is likely to go to the next support level at $2.96. Should the price break the second support level, the third support level stands at $2.35.
enVVeno Medical Corporation (NASDAQ: NVNO) Key Stats
There are currently 17,536K shares outstanding in the company with a market cap of 67.16 million. Presently, the company’s annual sales total 0 K according to its annual income of -21,820 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -4,500 K.
